Baeten Jared M, Lavreys Ludo, Overbaugh Julie
Department of Medicine, University of Washington, Seattle, WA, USA.
Clin Infect Dis. 2007 Aug 1;45(3):360-9. doi: 10.1086/519432. Epub 2007 Jun 18.
Women account for nearly one-half of new human immunodeficiency virus type 1 (HIV-1) infections worldwide, including the majority of infections in Africa. Biological and epidemiological studies suggest that hormonal contraceptive use could influence susceptibility to HIV-1, as well as infectivity and disease progression for those who become infected. However, not all studies have shown this relationship, and many questions remain. Safe and effective contraceptive choices are essential for women with and at risk for HIV-1 infection. Thus, understanding the effect, if any, of hormonal contraception on HIV-1 disease among women is a public health priority.
在全球范围内,感染新型人类免疫缺陷病毒1型(HIV-1)的人群中,女性占了近一半,其中非洲地区大多数感染者为女性。生物学和流行病学研究表明,使用激素避孕可能会影响对HIV-1的易感性,以及已感染者的传染性和疾病进展。然而,并非所有研究都证实了这种关系,许多问题依然存在。对于感染HIV-1的女性以及有感染风险的女性而言,安全有效的避孕选择至关重要。因此,了解激素避孕对女性HIV-1疾病的影响(如果有影响的话)是一项公共卫生重点工作。